Study to Evaluate the Safety and Preliminary Efficacy of IDCT, a Treatment for Symptomatic Lumbar Intervertebral Disc Degeneration

Exclusion Criteria

• •1. Symptomatic involvement of more than one lumbar disc.
• •2. Other persistent pain/nerve issues including, for example, radiculopathy, leg pain, cauda equine syndrome, etc.
• •3. Fracture of the spine, previous lumbar spine surgery or previous treatment of the target disc.
• •4. Evidence of dynamic instability on lumbar flexion-extension radiographs.
• •5. Grade 2 or higher spondylolisthesis at the target disc, lumbar spondylitis or other undifferentiated spondyloarthropathy, or Type III Modic changes around the target disc.
• •6. Clinical suspicion of a full thickness annular tear at the target disc or other abnormal disc morphology.
• •7. Clinical suspicion of facet pain as primary pain generator.
• •8. Subjects who test positive for communicable disease, have significant systemic disease, or are prone to infection.
• •9. Patients who are deemed unsuitable for clinical study participation by the investigator.